Champions Oncology (NASDAQ:CSBR) Earnings Information
Champions Oncology last released its earnings data on March 11th, 2021. The biotechnology company reported $0.05 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.04. The company had revenue of $10.81 million for the quarter, compared to analyst estimates of $10.29 million. Champions Oncology has generated ($0.17) earnings per share over the last year. Champions Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 26th, 2021 based off prior year's report dates.
Champions Oncology Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Champions Oncology (NASDAQ:CSBR) Earnings Estimates
Current Year EPS Consensus Estimate: $0.02 EPS
Next Year EPS Consensus Estimate: $0.15 EPS
Champions Oncology (NASDAQ CSBR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)